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OBJECTIVES: Video laparoscopic bariatric surgery is the preferred surgical technique for treating morbid
obesity. However, pneumoperitoneum can pose risks to the kidneys by causing a decrease in renal blood flow.
Furthermore, as in other surgical procedures, laparoscopic bariatric surgery triggers an acute inflammatory
response. Neutrophil gelatinase-associated lipocalin is an early and accurate biomarker of renal injury, as well
as of the inflammatory response. Anesthetic drugs could offer some protection for the kidneys and could
attenuate the acute inflammatory response from surgical trauma. The objective of this study was to compare
the effects of two types of anesthetics, propofol and sevoflurane, on the serum levels of neutrophil gelatinase-
associated lipocalin during the perioperative period in laparoscopic bariatric surgery.
METHODS: Sixty-four patients scheduled for laparoscopic bariatric surgery were randomized into two
anesthesia groups and were administered either total intravenous anesthesia (propofol) or inhalation
anesthesia (sevoflurane). In the perioperative period, blood samples were collected at three time points (before
anesthesia, 6 hours after pneumoperitoneum and 24 hours after pneumoperitoneum) and urine output was
measured for 24 hours. Acute kidney injuries were evaluated by examining both the clinical and laboratory
parameters during the postoperative period. The differences between the groups were compared using non-
parametric tests. ReBEC (http://www.ensaiosclinicos.gov.br/rg/recruiting/): RBR-8wt2fy
RESULTS: None of the patients developed an acute kidney injury during the study and no significant differences
were found between the serum neutrophil gelatinase-associated lipocalin levels of the groups during the
perioperative period.
CONCLUSION: The choice of anesthetic drug, either propofol or sevoflurane, did not affect the serum levels of
neutrophil gelatinase-associated lipocalin during the perioperative period in laparoscopic bariatric surgery.
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& INTRODUCTION
The worldwide rates of surgical procedures for weight
control have been increasing to address the recent obesity
epidemic (1). Currently, video laparoscopic bariatric sur-
gery (VLBS) is considered the best surgical technique for
morbidly obese individuals who have health complications
associated with excess body fat (2). Despite the proven
benefits of VLBS, these procedures, like any other surgery,
can produce a pattern of systemic inflammatory responses.
VLBS also carries an inherent risk of pneumoperitoneum to
the kidneys due to elevated intra-abdominal pressure,
which reduces cortical capillary blood flow by increasing
renal vascular resistance. Consequently, the glomerular
filtration rate (GFR) is decreased and transient oliguria
occurs (3). Rhabdomyolysis, which is also associated with
bariatric surgery, is another cause of kidney injury, but it
appears to be less problematic in VLBS than in open surgery
(4). Acute kidney failure, which presents as a major
elevation in creatinine levels with oliguria, is not a common
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complication of VLBS when proper preventive measures are
followed during the perioperative period (4). However,
traditional laboratory markers, such as urea and creatinine,
are not sufficiently sensitive to detect subclinical acute
kidney injuries in this population (5).
Neutrophil gelatinase-associated lipocalin (NGAL), a 25-
kDa glycoprotein in the lipocalin family (6) is produced by
the epithelia of the kidneys, lungs, colon, liver, adipose
tissue and inflammatory cells. The most well-known
functions of NGAL are iron transport (7), apoptosis
regulation (8), infection control (9), structural development
(10) and renal recuperation (11). Clinical interest in NGAL is
related to the sensitivity and speed with which it is elevated
in the serum and urine after acute tubular injury, enabling
the diagnosis of renal damage within 2 hours of the
injurious event. In comparison, the elevation of other
traditional markers, such as creatinine, can be delayed by
up to 48 hours after an acute kidney injury (5). Various other
causes of organ stress are also associated with NGAL
elevation, which can be mediated by pro-inflammatory
cytokines (12) and is considered a marker of a systemic
inflammatory response (13).
General anesthesia, commonly used in procedures such
as VLBS, can have protective effects on the renal system
during the intraoperative period. Though different mechan-
isms, both propofol (14) and sevoflurane (15) have appeared
to reduce renal injury in clinical-surgical and experimental
injury models. Various markers are measured serially to
monitor kidney injury during the perioperative period, but
many of these markers are delayed, or they have sensitivity
limitations. The purpose of the present study was to
compare the effects of two anesthetics, propofol (TIVA)
and sevoflurane (SEVO), on serum NGAL levels over a 24-
hour perioperative period in obese patients undergoing
VLBS.
& METHODS
This study was approved by the Committee of Research
Ethics of the Sa˜o Rafael Hospital (HSR) in Salvador, Bahia,
Brazil, in accordance with the national standards of ethics
on human experimentation, as well as the Helsinki
Declaration of 1975 and it was also registered at ReBEC
(http://www.ensaiosclinicos.gov.br/rg/recruiting/): RBR-
8wt2fy. Informed consent was obtained from 64 morbidly
obese patients who were scheduled to undergo VLBS
between October 2010 and July 2011. The surgical indica-
tions followed the current recommendations of the Brazilian
Society of Metabolic and Bariatric Surgery (individuals who
are incapable of losing weight with recognized clinical
treatments and have either a body mass index
(BMI).40 kg/m2 or.35 kg/m2 with obesity-related ill-
nesses). The following medical conditions were considered
the exclusion criteria for the study: chronic obstructive
pulmonary disease, congestive heart failure, cancer, chronic
steroid use and a GFR ,60 mL/min (as estimated by the
Cockcroft-Gault equation (16) using lean body weight for
the calculation (17)). The gastric bypass technique was used
in all of the patients. Two teams of surgeons performed the
procedures.
The patients were randomly placed into either the TIVA
or SEVO group. Both groups received 5 mg of midazolam as
premedication.
Induction of general anesthesia was accomplished with
propofol plus fentanyl in both groups; the SEVO group
received a propofol dose of 1 mg/kg (real body weight) and
the TIVA group received a propofol dose calculated by a
target controlled infusion pump. Fentanyl (5 mcg/kg; ideal
body weight) was used in both groups.
Maintenance of general anesthesia was assured using a
combination of sevoflurane plus remifentanil in the SEVO
group or of propofol plus remifentanil in the TIVA group.
For the SEVO group, sevoflurane was administered
throughout the surgery at a dose of between 1.4% and 3%
of the expiratory gas concentration. For the TIVA group, the
target controlled propofol infusion was at an estimated 3 to
5 mcg/mL blood concentration. Both groups received a
continuous, target-controlled remifentanil infusion (at an
estimated 3 to 6 ng/mL blood concentration, according to
clinical necessity).
Morphine (100 mcg/kg of ideal body weight), dipyrone
(2000 mg) and ondansetron (8 mg) were administered
intravenously 30 minutes before the expected termination
of surgery for postoperative analgesia and nausea preven-
tion (both groups).
Neuromuscular blocking agents were the same in both
groups and a succinylcholine dose of 1 mg/kg (ideal body
weight) was used to induce patients with expected difficult
airways. Also, cisatracurium was employed during the
procedure.
Perioperative hydration was provided identically to both
groups. A 0.9% NaCl solution was administered as an
infusion of 18 mL/kg (ideal body weight) for the first hour,
14 mL/kg (ideal body weight) for the second and third
hours and 10 mL/kg (ideal body weight) for subsequent
hours. Blood samples for measuring creatinine and NGAL
were collected at three time points: M0, immediately before
anesthesia induction; M1, 6 hours after pneumoperitoneum
was established; and M2, 24 hours after pneumoperito-
neum. Creatinine was measured by an automated chroma-
tographic technique immediately after the blood sample
was collected. NGAL was measured by the enzyme-linked
immunosorbent assay (ELISA) technique (NGAL rapid
ELISA kit; BioPorto, Gentofte, Denmark), which was retro-
spectively conducted on serum stored at -80 C˚. The patients
underwent bladder catheterization after anesthesia was
induced to measure 24 hours of urine output. The GFR at
the M1 and M2 time points was calculated by the Cockcroft-
Gault equation, using lean body weight (17). Blood pressure
levels were measured every five minutes via a non-invasive
method (oscillometry) and the average mean arterial
pressure was calculated at the following time points relative
to surgery: before anesthesia induction, after tracheal
intubation, during pneumoperitoneum, after pneumoper-
itoneum deflation and after tracheal extubation. The intra-
abdominal pressure during pneumoperitoneum was limited
to 14 cm H2O in all of the patients. Capillary blood glucose
was monitored (Accu-Chek, Roche Diagnostics GmbH
Sandhofer Strasse 116 D-68305 Mannheim, Germany) before
anesthesia induction and then every hour during surgery.
Statistical analysis
The sample size was calculated using estimates in the
literature regarding the mean and standard deviation for
NGAL levels in obese patients. To achieve power of 80% with
a 5% significance level and a difference of 33% in mean NGAL
serum levels, the sample size was estimated as 30 patients per
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group. The means of the independent continuous variables
were compared between the groups by the Mann-Whitney
test and Wilcoxon’s test was used to compare the dependent
variables within the same group (at different time points). The
chi-square test and Fisher’s exact test were used to analyze the
categorical variables. Differences with p-values ,0.05 were
considered significant.
& RESULTS
Sixty-eight patients were initially considered candidates for
participation in the study; however, 4 patients were excluded
before the random selection stage because they refused to
participate, or their surgeries were cancelled. Of the 64 patients
who were randomly selected, all of them completed the study
in two equally distributed groups of 32 individuals each.
There were no significant differences between the groups
in terms of the anthropometric data, sex distribution,
associated diseases, duration of pneumoperitoneum, base-
line GFR or average intra-abdominal pressure (Table 1).
As shown in Table 2, the serum levels of NGAL were not
influenced by the type of anesthesia that was used (TIVA vs.
SEVO) at any of the analyzed time points. No changes in the
NGAL levels were observed during the periods between M0
and M1, between M1 and M2 or between M0 and M2 in
either the individual patients or in the groups when they
were analyzed separately.
No difference was found in the occurrence of the ‘‘risk of
renal injury’’ between the two anesthesia groups during the
periods measured and no patients were classified as having
‘‘renal injury’’ using the RIFLE criteria (Table 3).
& DISCUSSION
Morbidly obese patients present a perioperative risk for
acute kidney injury due to various factors. The causes for
the occurrence of acute kidney damage found in the
literature included the following: the production of bioac-
tive substances by adipose tissues (18); an increase in the
intra-abdominal pressure due to visceral fat accumulation;
and tubular damage induced by rhabdomyolysis during
surgery (4). Temporary oliguria is also a well-documented
complication of laparoscopy, particularly in morbidly obese
patients (19). The primary factors causing kidney injury
during laparoscopic procedures were abdominal insuffla-
tion pressure and the length of pneumoperitoneum expo-
sure (20). A decrease in the cortical blood flow, as well as an
increase in vascular resistance and transient ischemia, was
commonly observed under experimental conditions, but
these effects were usually associated with elevated insuf-
flation pressure of the abdominal cavity (.15 mm Hg) (20)
and they were typically reversible by ending the pneumo-
peritoneum (19).
In 15.6% of the patients at time point M1 and 1.6% of the
patients at time point M2, we found temporary changes in
the urine volume and serum creatinine levels that were
sufficiently large to be classified as at ‘‘risk’’ using the
RIFLE criteria; there was no significant difference between
Table 1 - Demographic data according to the anesthesia type (32 patients in each group).
VARIABLE
TOTAL INTRAVENOUS
ANESTHESIA SEVOFLURANE ANESTHESIA p-VALUE
Age (years) a c 34 (28/45) 33 (28/39) 0.371
Weight (kg) a c 105 (94/125) 104 (97/120) 0.995
Body mass index (kg/m2) a c 40 (38/42) 38 (37/43) 0.528
Sex (male) b d 7 (22%) 9 (28%) 0.774
Systemic arterial hypertension b d 17 (53%) 16 (50%) 0.802
Diabetes mellitus b d 14 (43%) 11 (34%) 0.442
GFR baseline (mL/min) a c 97 (81/119) 103 (82/108) 0.601
Duration of pneumoperitoneum (min) a c 135 (115/149) 130 (111/144) 0.523
Intra-abdominal pressure during pneumoperitoneum (mm Hg) a c 13.55 (13/14) 13.00 (13/14) 0.248
a The median value (1st and 3rd quartiles) is reported for the age, weight, BMI, GFR, duration of pneumoperitoneum and intra-abdominal pressure during
pneumoperitoneum.
b The other variables are expressed as the absolute and relative frequencies.
c The Mann-Whitney test was used to compare the weight, age, BMI, duration of pneumoperitoneum and intra-abdominal pressure during
pneumoperitoneum.
d Other variables were compared using the chi-square test and Fisher’s exact test.
Table 2 - The median neutrophil gelatinase-associated lipocalin levels (ng/mL) (1st and 3rd quartiles) before anesthesia, 6
hours after pneumoperitoneum and 24 hours after pneumoperitoneum in all of the patients, separated according to
type of anesthesia, total intravenous or inhalation anesthesia sevoflurane.
GROUP BEFORE ANESTHESIA
6 HOURS AFTER THE
BEGINNING OF SURGERY
24 HOURS AFTER THE
BEGINNING OF SURGERY
Sevoflurane 29.0 (17.5/43.5)a.e 30.0 (21.5/69.5)b.e 24.5 (16.5/43.2)c.e
TIVA 31.0 (20.0/51.0)a.f 26.5 (18.7/51.2)b.f 22.0 (14.0/51.0)c.f
All patients 30.0 (19.0/46.25)d 29.0 (21.0/60.0)d 24.0 (15.0/47.0)d
a Comparison of the values in the SEVO vs. TIVA groups for M0, p=0.376.
b Comparison of the values in the SEVO vs. TIVA groups for M1, p=0.309.
c Comparison of the values in the SEVO vs. TIVA groups for M2, p=0.917.
d Comparison of the values in all of the patients across different periods: M1-M0, p=0.227; M2-M1, p=0.533; and M2-M0, p=0.894.
e Comparison of the values within the SEVO group across different periods: M1-M0, p=0.083; M2-M1, p=0.913; and M2-M0, p=0.421.
f Comparison of the values within the TIVA group across different periods: M1-M0, p=0.914; M2-M1, p=0.715; and M2-M0, p=0.966.
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the types of anesthesia (Table 3). All of the individuals
classified as at ‘‘risk’’ of renal injury using the RIFLE criteria
at M1 had their classifications reversed to normal in M2. No
patients were considered at risk according to the RIFLE
classification at hospital discharge. Similarly, in a study by
Ettinger et al. (4), the authors could not find any cases of
acute tubular necrosis (creatinine elevation criteria) in 58
morbidly obese patients who underwent VLBS under
similar conditions. We also observed that the serum
NGAL levels were not significantly different at the three
different time points at which they were measured over the
24 hours of the perioperative period (Table 2). Similarly,
Micalli et al. (21) did not observe any changes in the urinary
levels of N-acetyl-b-D-glucosaminidase, a urinary marker of
renal injury, in patients who had undergone surgical
laparoscopy. In our study, low intra-abdominal pressures
were used during the surgical procedures (the pneumoper-
itoneum was limited to 14 mm Hg), which might have
contributed to the absence of observable clinical damage to
the renal system.
As seen in Table 2, the type of general anesthesia (TIVA
vs. SEVO) did not influence the serum NGAL levels at any
time during the evaluated perioperative period. Both
propofol and sevoflurane are anti-inflammatory agents
because they decrease the production of the nuclear
transcription factor (NF-kB) (15,22), which is considered a
transcriptional inducer of pro-inflammatory interleukins,
such as interleukins 1 and 6 (23) and of NGAL itself (24).
Through different mechanisms, both sevoflurane and
propofol exert protective effects on the kidneys: propofol
decreased the tissue damage caused by oxidative stress (25)
and in renal ischemia models, sevoflurane provided
pharmacological preconditioning (15,26). However, there
has been no consensus in the literature regarding the more
effective drug for kidney protection.
Although VLBS carries a risk of acute kidney injury,
proper perioperative care greatly reduces its occurrence and
traditional laboratory markers do not have sufficient
accuracy to identify subclinical damage. NGAL is a
sensitive, specific and early biomarker of acute kidney
injury that has been tested under many clinical conditions
and it allows for diagnosing renal damage within two hours
of the injurious event (5). In our study, there were no
significant differences in the perioperative blood levels of
this highly accurate biomarker between groups using
propofol or sevoflurane to maintain general anesthesia
during VLBS.
The type of general anesthesia (TIVA vs. SEVO) did not
influence serum NGAL levels during the perioperative
period in VLBS. Therefore, with regard to the risk of acute
kidney injury, both types of anesthesia were equally safe
during this surgery.
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